The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease (vol 41, 92, 2022)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH(2023)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要